The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $31.25

Today's change-0.58 -1.82%
Updated January 30 4:00 PM EST. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $31.25

Today's change-0.58 -1.82%
Updated January 30 4:00 PM EST. Delayed by at least 15 minutes.

Pfizer Inc crosses below 50-day moving average

Pfizer Inc closed sharply lower Friday, dropping (U.S.)$0.58 or 1.82% to (U.S.)$31.25 and crossing below its 50-day moving average. Shares have lost 3.70% over the last five days, but are unchanged over the last 52 weeks. This security has underperformed the S&P 500 by 9.80% during the last year.

Key company metrics

  • Open(U.S.) $31.67
  • Previous close(U.S.) $31.83
  • High(U.S.) $31.80
  • Low(U.S.) $31.20
  • Bid / Ask-- / --
  • YTD % change+0.32%
  • Volume43,070,750
  • Average volume (10-day)33,646,394
  • Average volume (1-month)29,201,646
  • Average volume (3-month)25,221,968
  • 52-week range(U.S.) $27.51 to (U.S.) $33.50
  • Beta0.71
  • Trailing P/E22.05×
  • P/E 1 year forward14.92×
  • Forward PEG5.19×
  • Indicated annual dividend(U.S.) $1.12
  • Dividend yield3.58%
  • Trailing EPS(U.S.) $1.42
Updated January 30 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.39%

Based on its net profit margin of 18.39%, Pfizer Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.25%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 28, 201409/28/2014Jun 29, 201406/29/2014Mar 30, 201403/30/2014Dec 31, 201312/31/2013
Revenue12,36112,77311,35313,558
Total other revenue--------
Total revenue12,36112,77311,35313,558
Gross profit9,99310,3279,31410,788
Total cost of revenue2,3682,4462,0392,770
Total operating expense8,6218,5998,44010,625
Selling / general / administrative3,5433,5203,0404,117
Research & development1,8021,7591,6231,788
Depreciation / amortization9721,0011,1171,123
Interest expense (income), net operating--------
Unusual expense (income)26595873979
Other operating expenses, total-329-222-252-152
Operating income3,7404,1742,9132,933
Interest income (expense), net non-operating-343-343-321-347
Gain (loss) on sale of assets5333181220
Other--------
Income before tax3,5874,0032,8473,061
Income after tax2,6762,9212,2652,631
Income tax, total9111,082582430
Net income2,6672,9122,3292,569
Total adjustments to net income-1-10-1
Net income before extra. items2,6702,9122,2562,626
Minority interest-6-9-9-5
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,6692,9112,2562,625
Inc. avail. to common incl. extra. items2,6662,9112,3292,568
Diluted net income2,6662,9122,3292,569
Dilution adjustment--1--1
Diluted weighted average shares6,4036,4446,4766,532
Diluted EPS excluding extraordinary itemsvalue per share0.420.450.350.40
Dividends per sharevalue per share0.260.260.260.24
Diluted normalized EPSvalue per share0.450.450.450.50